These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 35078211)

  • 1. Autoantibody profiles associated with morbidity and mortality in scleroderma renal crisis.
    Tsuji H; Kuramoto N; Sasai T; Shirakashi M; Onizawa H; Kitagori K; Akizuki S; Nakashima R; Watanabe R; Onishi A; Murakami K; Yoshifuji H; Tanaka M; Hashimoto M; Ohmura K; Morinobu A
    Rheumatology (Oxford); 2022 Oct; 61(10):4130-4135. PubMed ID: 35078211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gender and ethnicity differences in the prevalence of scleroderma-related autoantibodies.
    Krzyszczak ME; Li Y; Ross SJ; Ceribelli A; Chan EK; Bubb MR; Sobel ES; Reeves WH; Satoh M
    Clin Rheumatol; 2011 Oct; 30(10):1333-9. PubMed ID: 21523365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serologic profile and mortality rates of scleroderma renal crisis in Italy.
    Codullo V; Cavazzana I; Bonino C; Alpini C; Cavagna L; Cozzi F; Del Papa N; Franceschini F; Guiducci S; Morozzi G; Ruffatti A; Ferri C; Giacomelli R; Matucci-Cerinic M; Valentini G; Montecucco C
    J Rheumatol; 2009 Jul; 36(7):1464-9. PubMed ID: 19487262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoantibodies in systemic sclerosis.
    Steen VD
    Semin Arthritis Rheum; 2005 Aug; 35(1):35-42. PubMed ID: 16084222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of HLA class II genes with systemic sclerosis in Koreans.
    Kang SH; Park MH; Song EY; Kang SJ; Lee EB; Song YW; Takeuchi F
    J Rheumatol; 2001 Jul; 28(7):1577-83. PubMed ID: 11469465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Autoantibodies in systemic sclerosis and their clinical correlation in patients from a Midwestern region of Brazil].
    Coelho Horimoto AM; da Costa IP
    Rev Bras Reumatol; 2015; 55(3):229-39. PubMed ID: 25559063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between autoantibodies in systemic sclerosis and cancer in a national registry.
    Hoa S; Lazizi S; Baron M; Wang M; Fritzler MJ; Hudson M;
    Rheumatology (Oxford); 2022 Jul; 61(7):2905-2914. PubMed ID: 34599801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and serological associations with anti-RNA polymerase antibodies in systemic sclerosis.
    Harvey GR; Butts S; Rands AL; Patel Y; McHugh NJ
    Clin Exp Immunol; 1999 Aug; 117(2):395-402. PubMed ID: 10444276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoantibody profiles in systemic sclerosis: predictive value for clinical evaluation and prognosis.
    Hamaguchi Y
    J Dermatol; 2010 Jan; 37(1):42-53. PubMed ID: 20175839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic sclerosis: demographic, clinical and serological features in 100 Iranian patients.
    Poormoghim H; Moghadam AS; Moradi-Lakeh M; Jafarzadeh M; Asadifar B; Ghelman M; Andalib E
    Rheumatol Int; 2013 Aug; 33(8):1943-50. PubMed ID: 23344826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Demographic and clinical features of systemic sclerosis patients with anti-RNA polymerase III antibodies.
    Motegi S; Toki S; Yamada K; Uchiyama A; Ishikawa O
    J Dermatol; 2015 Feb; 42(2):189-92. PubMed ID: 25483258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extended autoantibody panel in Turkish patients with early-stage systemic sclerosis: Coexpressions and their influences on clinical phenotypes.
    Temiz Karadağ D; Komac A; Erez Y; Birlik AM; Sari A; Akdoğan A; Farisogullari B; Kimyon G; Koc E; Arslan D; Karatas A; Koca SS; Kasifoglu N; Yazici A; Hayran KM; Cefle A
    Immun Inflamm Dis; 2023 Dec; 11(12):e1089. PubMed ID: 38134320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of clinical features, serum antinuclear antibodies, and lung function on survival of patients with systemic sclerosis.
    Jacobsen S; Ullman S; Shen GQ; Wiik A; Halberg P
    J Rheumatol; 2001 Nov; 28(11):2454-9. PubMed ID: 11708418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using Autoantibodies and Cutaneous Subset to Develop Outcome-Based Disease Classification in Systemic Sclerosis.
    Nihtyanova SI; Sari A; Harvey JC; Leslie A; Derrett-Smith EC; Fonseca C; Ong VH; Denton CP
    Arthritis Rheumatol; 2020 Mar; 72(3):465-476. PubMed ID: 31682743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical features of Japanese systemic sclerosis (SSc) patients negative for SSc-related autoantibodies: A single-center retrospective study.
    Miyake M; Matsushita T; Takehara K; Hamaguchi Y
    Int J Rheum Dis; 2020 Aug; 23(9):1219-1225. PubMed ID: 32662135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoantibodies in scleroderma and their association with the clinical profile of the disease. A study of 66 patients from southern Brazil.
    Skare TL; Fonseca AE; Luciano AC; Azevedo PM
    An Bras Dermatol; 2011; 86(6):1075-81. PubMed ID: 22281893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk Factors for Future Scleroderma Renal Crisis at Systemic Sclerosis Diagnosis.
    Gordon SM; Stitt RS; Nee R; Bailey WT; Little DJ; Knight KR; Hughes JB; Edison JD; Olson SW
    J Rheumatol; 2019 Jan; 46(1):85-92. PubMed ID: 30008456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antinuclear antibody pattern and autoantibody profiling of systemic sclerosis patients in a tertiary referral center in North India.
    Machhua S; Sharma SK; Kumar Y; Anand S; Handa S; Minz RW
    Pathol Int; 2022 May; 72(5):283-292. PubMed ID: 35319814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and immunologic predictors of scleroderma renal crisis in Japanese systemic sclerosis patients with anti-RNA polymerase III autoantibodies.
    Hamaguchi Y; Kodera M; Matsushita T; Hasegawa M; Inaba Y; Usuda T; Kuwana M; Takehara K; Fujimoto M
    Arthritis Rheumatol; 2015 Apr; 67(4):1045-52. PubMed ID: 25512203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scleroderma renal crisis in a Swedish systemic sclerosis cohort: survival, renal outcome, and RNA polymerase III antibodies as a risk factor.
    Hesselstrand R; Scheja A; Wuttge DM
    Scand J Rheumatol; 2012 Feb; 41(1):39-43. PubMed ID: 22044051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.